📰 4 sources covering this story

Eli Lilly diabetes drug wins FDA approval to lower cardiovascular risks

First covered 3 hrs ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

The Independent1 hrs ago

Heart disease is is the leading cause of death for people with Type 2 diabetes

Trust?Read on The Independent ↗

Reuters2 hrs ago

US FDA approves Lilly's Mounjaro to reduce cardiovascular risk

US FDA approves Lilly's Mounjaro to reduce cardiovascular risk Reuters

Trust?Read on Reuters ↗

USA Today3 hrs ago

Eli Lilly's diabetes drug Mounjaro gets approval for a new use

Eli Lilly's diabetes drug Mounjaro gets approval for a new use USA Today

Trust?Read on USA Today ↗

Quartz🏁 first to report3 hrs ago

Eli Lilly's diabetes drug wins FDA approval to lower heart attack and stroke risk

The diabetes drug, already the top-prescribed branded type 2 diabetes medicine in the U.S., showed an 8% lower rate of major heart events than Lilly's older drug Trulicity

Trust?Read on Quartz ↗